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Background & aims: Treatment of depression in elderly population is a crucial issue. The effect of vitamin
D supplementation on treatment of depression in older adults was investigated in this clinical trial.
Methods: It was an 8-week, randomized clinical trial of vitamin D supplementation and placebo in the
treatment of depression in 3 psychiatric clinics. The study sample included 78 older adults aged over 60
years with moderate to severe depression. Subjects were randomly allocated to receive 50,000 U vitamin
D3 pearl weekly for 8 weeks or placebo (39 subjects in each group). Main outcome measures comprised
Geriatric Depression Scale-15 (GDS-15) questionnaire and 25-hydroxyvitamin D3 [25(OH)D3]. The
analysis utilized Mann Whitney U test, Wilcoxon signed ranks test, chi-square and multiple regression
analysis.
Results: The mean baseline 25(OH)D3 concentration was 22.57 ± 6.2 ng/ml in vitamin D group and
21.2 ± 5.8 ng/ml in placebo group (p ¼ 0.16). The Vitamin D increased to 43.48 ± 9.5 ng/ml in vitamin D
and 25.9 ± 15.3 ng/ml in placebo group. The depression score decreased from 9.25 to 7.48 in vitamin D
group (p ¼ 0.0001), while there was a non-signiﬁcant increase in depression score in placebo group. The
multiple regression analysis showed that the vitamin D group and the score of depression before study
were the variables that could explain 81.8% of depression score after intervention.
Conclusion: The ﬁndings indicated that vitamin D supplementation can improve the depression score in
persons aged 60 and over.
© 2018 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.1. Introduction
Depression is a common problem in older adults [1], with many
consequences such as loss of appetite and energy, insomnia, and
loss of interest in usual activities [2]. These patients feel anxious
and dissatisﬁed with their lives [3]. Depression has adverse effects
on physical performance and the quality of life of older adults [4,5].
A meta-analysis of 83 studies from all around the world showed
that the prevalence of depression and depressive symptoms in
adults aged 60 years and over was 27% whereas the highest
depression prevalence of 34%was reported in persons older than 80
years [6]. It is also estimated that 8e16% of older adults haveian Registry of Clinical Trials
://www.irct.ir/trial/22570.
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major depression [7]. In Iranian Turkmens the elderly depression
prevalence was 20% [8]. In nursing homes the prevalence can in-
crease up to 95.64% [9].
Vitamins play an important role in the functions of the body
[10]. Vitamin D is accessible in enriched nutritionals and supple-
ments as ergocalciferol-D2 and cholecalciferol-D3. Central nervous
system, including the amygdala -the area that controls emotions
and behaviors in humans- has receptors for vitamin D and its
enzyme activators. Some believe that vitamin D might affect
depressive symptoms [11]. An experimental study showed that
mice that were fed a vitamin D deﬁcient diet for 10 weeks had
reduction in the enzymes involved in GABA synthesis and displayed
altered behavior, and an enhanced response to aversive stimuli
such as heat and sound. This was accompanied by alterations in
amino acid metabolism within the brain [12].
Vitamin D can be supplied through sun exposure, but studies
show that vitamin D deﬁciency is very common [13,14], and manyism. All rights reserved.
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tionship between vitamin D and depressive symptoms have
different results. A study in the United States, suggested that low
vitamin D levels were associated with depression although the
subjects were between 15 and 39 years old [16]. The cross-sectional
study in older adults, showed that the prevalence of depressionwas
twice in seniors with low vitamin D levels compare to those
without deﬁciency [17]. But two major studies in adults in United
Stated and China showed no relationship between vitamin D level
and depression [18,19]. In a cohort study in the Netherlands there
was no effect of vitamin D levels on the course of depression or
remission rates in older persons [20]. Almeida showed that Vitamin
D deﬁciency was associated with current depression, although this
study did not support the role for vitamin D in the causation of
depression [21]. Given the conﬂicting and different results about
the relationship between vitamin D and elderly depression, a meta-
analysis was conducted by Anglin in 2013. In this study a slight
association between depression and low levels of vitamin D was
found. The researchers noted that studies on the impact of vitamin
D intervention in the treatment or prevention of depression are
necessary [22].
There are few clinical trials about the effect of vitamin D on
depressive symptoms in older adults. In a systematic review in
2014, all the intervention studies on the effect of vitamin D on
depression were evaluated. Only seven clinical trials were found.
The results of the meta-analysis showed that the total effect of
vitamin D was negligible and not signiﬁcant. The researchers
concluded that this issue needs further investigation [23]. Another
meta-analysis in 2015, reported no signiﬁcant reduction in
depression following vitamin D supplementation [24]. The most
recent review in elderly population showed an inverse association
between vitamin D blood level and depression in observational
studies but only one clinical trial showed the signiﬁcant difference
in depression after vitamin D prescription [25].
It seems that there are several meta-analysis and systematic
reviews in this ﬁeld that have used the limited number of repeated
and inconsistent studies for their conclusions. The older adults have
not been target population, and the duration of the intervention
has not been adequate in many studies. Some researchers have
used the daily supplement of vitamin D that decrease the compli-
ance of the subjects and to our knowledge therewas no clinical trial
about vitamin D and depression in older adults in Iran.
Prevention and treatment of depression in elderly population is
a crucial issue and vitamin D might have a potential impact on
depression. Few randomized placebo-clinical trials (RCTs) have
been done to examine the effect of vitamin D supplement in
treatment of depression in older adults, so the aim of this clinical
trial was to investigate the effect of vitamin D supplementation on
the severity of depression in elderly population in 2016e2017.
2. Materials and methods
2.1. Participants
This randomized placebo-controlled trial was conducted in 3
psychiatric clinics, during March 2016 to February 2017. For esti-
mating sample size, the type 1(a) and type 2 errors (b) of 0/05 and 0/
20 (power ¼ 80%) were calculated respectively. We reached the
sample size of 40 participants for each group using the suggested
formula for parallel clinical trials. In this study we included patients
aged over 60 years who were under treatment for depression. Other
inclusion criteria were Iranian citizenship, the ability to speak Farsi
and answer the questions, no history of mental illness other than
depression, no history of physical disability, and GDS- Geriatric
Depression Scale- score above 5 that represents moderate to severePlease cite this article in press as: Alavi NM, et al., Effect of vitamin D supp
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continue the treatment and those with severe stress such as hospi-
talization or death of relatives were excluded from the study.
The eligible patients were randomly assigned to vitamin D
group (n¼ 40) or placebo (n¼ 40) for 8weeks. Random assignment
was done by computer-generated random numbers. Randomiza-
tion and allocation were concealed from researcher and partici-
pants until the main analyses were completed. A trained nurse at
the psychiatric clinic, assigned participants to intervention and
control groups randomly.
Ethical statement: This study was done according to guidelines
published in the Declaration of Helsinki. This study was approved
by the ethics committee of the X University of Medical Sciences
with the grant NO: 93160 and registered on the Iranian Registry of
Clinical Trials website with the number IRCT201604252758N1.
Written informed consent was obtained from all study subjects
before commence recruitment.
2.2. Study design
Individual in vitamin D group received 50,000 units of vitamin
D3 pearl weekly for 8 weeks at the mealtime. Individuals in the
placebo group received placebo weekly in the same time. The
vitamin D3 supplement and its placebo were produced by Osvah
pharmaceutical corporation, Tehran, Iran. Routine treatments for
depression were continued for both groups. The appearance of the
supplement and placebo was identical (i.e. Size, packaging and
shape). Vitamin D3 and their placebo were packed in the same
packages and coded by the producer to insure blinding. Participants
were asked not to change their routine physical activity or usual
dietary intakes during the study. Adherence to vitamin D3 sup-
plement checked by asking the patients to bring the medication
containers, and counting the remained pearls.
2.3. Measurements
For vitamin Dmeasurement, at the baseline and after 8 weeks of
the intervention, 5e6 ml non-fasting venous blood samples were
taken at the University laboratory. Serums were sent to the Vakili's
Laboratory. The 25-OH vitamin D3 was determined by DiaSorin
LIAISON 25 OH Vitamin D TOTAL Assay uses chemiluminescent
immunoassay (CLIA), (brand: Diasorin S.P.A, Italy, build number:
133193 and expiration date: 19/4/2017). The 25-OH vitamin D level
less than 30 ng/ml was considered as deﬁciency and 30e100 ng/ml
as normal range [26].
Geriatric Depression Scale-15 (GDS-15) was used for assessment
of depression. GDS has been developed by Yesavage and Brink in
1983, and it has been translated and used extensively in different
countries [27]. The GDS-15 has been translated into Farsi by Mala-
kouti. In his study on 204 older adults in Iran, its internal consistency
(alpha-cronbach index), and split-half coefﬁcients were reported to
be 0.9, and 0.89 respectively. The factor analysis also approved the
construct validity of this questionnaire [27]. This instrument has
been used in some other studies in Iran [28e30]. This scale has 15
dichotomous items. One can get the score between 0 and 15 from
this scale. The score above 5 suggests mild to moderate depression,
and score above 10 is indicating severe depression [31].
2.4. Statistical analysis
The normality of the variables was evaluated by using
KolmogoroveSmirnov test. The demographic characteristics of the
participants in vitamin D and placebo groups such as sex and ed-
ucation were compared with chi-square test, the depression
severity as category was analyzed by Fisher's exact test. Vitamin Dlementation on depression in elderly patients: A randomized clinical
Fig. 1. Summary of participant's ﬂow diagram. Individual in the vitamin D group Received 50,000 U vitamin D3 pearls weekly for 8 weeks, and those in placebo group received
placebo.
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vitamin D level before intervention in vitamin D group, depression
before intervention in placebo group and difference in vitamin D
and depression in both groups were not distributed normally so the
differences of vitamin D levels, and GDS scores between groups
were analyzed using Mann Whitney U test, and values before and
after intervention were analyzed using Wilcoxon signed ranks test.
Depression score after intervention had normal distribution and
it was considered as dependent variable in multiple regression
analysis. The other variables that showed correlationwith dependent
variable or theoretically could explain the depression were entered
to the multiple regression analysis. These variables were depression
before intervention, vitamin D levels before and after intervention,
group of intervention, sex, gender and duration of depression. All
analyses were conducted with SPSS version 16 (SPSS Inc., Chicago,
Illinois). p < 0:05 was used to identify statistical signiﬁcance.
3. Results
Only one individual in each group declined to participate in the
study and ﬁnally 78 individuals (vitamin D [N ¼ 39] and placebo
[N ¼ 39]) completed the trial (Fig. 1). For those who completed the
trial (n ¼ 78), the pearls counts showed 100% adherence in both
groups.
The mean ± SD age of subjects in vitamin D Group was 68.7
years (±7) and 67 years (±6.3) in placebo group, and almost half of
each group were female. The vitamin D and placebo groups had noPlease cite this article in press as: Alavi NM, et al., Effect of vitamin D supp
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pertension, and severity of depression. The participant's charac-
teristics can be seen in Table 1.
All the patients had vitamin D deﬁciency (vitamin D level less
than 30 ng/ml) before intervention. The mean baseline 25(OH)D3
concentrationwas 22.57 ± 6.2 ng/ml in vitamin D and 21.2 ± 5.8 ng/
ml in placebo group (p ¼ 0.16). The Vitamin D increased to
43.48 ± 9.5 ng/ml in vitamin D and 25.9 ± 15.3 ng/ml in placebo
group. Both groups showed signiﬁcant increase in vitamin D con-
centration although the increase was about 4 times greater in
vitamin D Group (Table 2). After intervention 36 subjects (92.3%) in
vitamin D group and 11 subjects (29.7%) in placebo group had
normal level of vitamin D concentration.
The Depression score decreased from 9.25 to 7.48 in vitamin D
group (p ¼ 0.0001), while there was a non-signiﬁcant increase in
depression score in placebo group (p ¼ 0.867). Before intervention
the severe depression (GDS > 10) was not signiﬁcantly different in
the groups. After intervention no patients in vitamin D group
showed severe depression but 10 patients (25.6%) in placebo group
had severe depression (p ¼ 0.001) (Table 3). The analysis showed
that vitamin D supplementation was associated with improvement
in depression score in elderly patients. No adverse effects were
reported during the trial.
The multiple regression analysis showed that the intervention
group and the score of depression before study were the variables
that could explain 81.8% of depression score after intervention
(R ¼ 0.905, R square ¼ 0.818, Adjusted R Square ¼ 0.8, plementation on depression in elderly patients: A randomized clinical
Table 2
Pre and post data for vitamin D status and Geriatric Depression Scale-15 (GDS-15) in vitamin D supplementation and placebo groups.
Groups Vitamin D supplementation (mean ± sd) Placebo (mean ± sd) P value
Vitamin D plasma concentration before Intervention (ng/ml) 22.57 ± 6.2 21.2 ± 5.8 0.160
Vitamin D plasma concentration after Intervention (ng/ml) 43.48 ± 9.5 25.9 ± 15.3 0.0001
P value 0.0001 0.021
vitamin D plasma concentration Difference (ng/ml) 20.9 ± 9.7 4.9 ± 13.5 0.0001
GDS-15 Scores before intervention 9.25 ± 2.4 8.9 ± 2.3 0.607
GDS-15 scores after intervention 7.48 ± 1.66 9 ± 2.1 0.002
P value 0.0001 0.867
GDS-15 scores difference 1.76 ± 1.28 0.027 ± 0.95 0.0001
Table 1
The patients' characteristics in Intervention and control groups.
Variables Vitamin D supplementation Placebo P value
Sex N (%) Male 20 (51.3) 19 (48.7) 0.821
Female 19 (48.7) 20 (51.3)
Education N (%) Illiterate 18 (46.2) 14 (35.9) 0.783
Under diploma 17 (43.6) 19 (48.7)
Diploma and higher 4 (10.3) 6 (15.4)
Hypertension N (%) 20 (51.3) 26 (66.7) 0.167
Diabetes N (%) 15 (38.5) 22 (56.4) 0.112
The history of depression N (%) 20 (51.3) 14 (32.9) 0.171
Age (mean ± sd) 68.7 ± 7 67 ± 6.3 0.313
Duration of depression (mean ± sd) 3.4 ± 3.5 3.1 ± 2.4 0.833
N.M. Alavi et al. / Clinical Nutrition xxx (2018) 1e64value ¼ 0.0001). The other variables did not make a signiﬁcant
contribution (Table 4).4. Discussion
In this study vitamin D supplementation could improve the
depression scores. There are many vitamin D receptors in hip-
pocampus that is associated to the depression, and vitamin D
metabolites can cross the bloodebrain barrier. So vitamin D
concentration may be effective in treatment of depression.
There are some systematic reviews about the vitamin D and
depression. In a recent one that has been published in 2016,
twenty observational (cross-sectional and prospective) studies
and 10 randomized trials were reviewed by Okereke. There was
an inverse association between vitamin D blood level and
depression in 13 observational studies but only one clinical trialTable 3
Number (%) of patients diagnosed with moderate/Severe depression according to the G
depression; >10 ¼ Severe depression).
GDS-15 Scores* Vitamin D
Before intervention Moderate depression 26 (66.7)
Severe depression 13 (33.3)
After intervention Moderate depression 39 (100)
Severe depression 0
Table 4
Multiple linear regression analysis using post-intervention Geriatric Depression Scale-15
Independent Variables B
Constant 0.387
GDS-15 scores before intervention .696
Intervention group (Vitamin D and Placebo) 1.571
Vitamin D plasma concentration before intervention .000
Vitamin D plasma concentration after intervention .008
Age .001
Sex .025
Duration of depression .043
Please cite this article in press as: Alavi NM, et al., Effect of vitamin D supp
trial, Clinical Nutrition (2018), https://doi.org/10.1016/j.clnu.2018.09.011showed the signiﬁcant difference in depression after vitamin D
prescription [25].
RCTs are important to determine whether vitamin D supple-
mentation is an effective treatment for depression. The available
studies have inconsistent results. This may relate to design limita-
tions (small sample size, different age range of subjects, vitamin D
dosage and method of administration, and depression measures).
Such limitations make it difﬁcult to generalize ﬁndings across
studies. In 2009, the seminal integrative literature review on
vitamin D and the occurrence of depression on older adults
determined the relationship between vitamin D and depression to
be largely circumstantial [30]. So the details in the methodology of
clinical trials and the precise protocol of systematic review have
crucial role in the ﬁndings and should be considered in any inter-
pretation [32]. Farrington in her systematic review suggested that
further research is needed with tightly controlled variables related
to age, gender, diet, seasonality, geographic location, measurementDS-15 score values (Geriatric Depression Scale-15 score 5e10 ¼ Mild to moderate
supplementation N (%) Placebo N (%) P value
27 (69.2) 0.678
12 (30.8)
29 (74.4) 0.001
10 (25.6)
(GDS-15) scores as dependent variable.
Standard Error Beta t P value
1.521 .254 .800
.047 .808 14.748 .000
.265 .384 5.931 .000
.020 .000 .006 .995
.010 .057 .781 .437
.017 .004 .066 .948
.223 .006 .111 .912
.039 .063 1.095 .277
lementation on depression in elderly patients: A randomized clinical
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[30]. Current research might be valuable for geriatric practitioners
because we limited our study to elderly patients with recognized
depression that were currently under treatment.
Recent studies focus on comparing the effects of an antide-
pressant and vitamin D supplementation with the patients
receiving only an antidepressant [33]. Current study also used the
same design and patients continue to receive their usual antide-
pressant treatments.
In a cohort study in England the researchers found that partic-
ipants with common mental disorders (depression, anxiety, panic,
phobia) showed inverse associations of vitamin D level with
depression and panic at 45 years old. The association between
vitamin D and risk of depressionwas non-linear in other age groups
[34]. This study showed that there might be more complex rela-
tionship between vitamin D and depression than thought before.
We limited our study to the patients aged over 60 years; this might
help to limit the effect of age on the results because most of the
previous studies were used wider ager groups.
In current study the researchers were successful in improving
the vitamin D blood levels in intervention group. One of the
reasons might be the weekly prescription of the supplement that
is easy and increase the compliance of the patients. Many
interventional studies have used the daily usage of vitamin D
that can decrease their effects [35e38]. There was a signiﬁcant
increase in vitamin D level in placebo group. The study started in
March that is concurrent with the long and sunny days. Most of
the patients were recruited to the study in spring and summer
time so the increase in vitamin D level in control group might be
due to sun exposure, although the increase was far less than
intervention group. The mild increase in vitamin D level in
control group did not show signiﬁcant effect on depression score
and its severity. It might show that there must be a certain level
of vitamin D concentration, before expecting any antidepressant
effects.
Vitamin D supplementation is a cost-effective method with
rare side-effects and with potential antidepressant effects ac-
cording to our ﬁndings. Vitamin D have other beneﬁts such as
improvement of muscle and skeletal performance, and relieving
fatigue [39]. A clinical trial showed that vitamin D supplementa-
tion can decrease the musculoskeletal pain [40]. We recommend
the evaluation of vitamin D serum levels in older adults with
depressive symptoms and prescription of vitamin D supplements
for at least 8 weeks in patients with deﬁciency, it is a safe
recommendation since vitamin D toxicity (above 100 ng/ml) [41]
is rare and this prescription might have other beneﬁts for older
people. Practitioners also can safely instruct their patients to have
more sun exposure.
This study had some limitations; ﬁrst there were some con-
founding variables that we could not control sufﬁciently such as the
severity of depression, the depression treatment, sun exposure of
the subjects, history of depression, cross contamination between
intervention and control group, and possible use of supplements by
control group. We tried to control these variables by random allo-
cation of the subjects to placebo and intervention groups.
In conclusion vitamin D supplementation signiﬁcantly
decreased GDS score in older adults. According to our ﬁndings the
older adults who are under treatment of depression could clinically
beneﬁt from vitamin D prescription. Although, there is a need for
more well designed randomized clinical trials in this ﬁeld.
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